scorecardresearch
Tuesday, August 26, 2025
TopicCovid cases

Topic: Covid cases

New COVID-19 sub-variants more severe than Omicron? India’s top virus research institute has answers

Virus isolation of the newer variants was in process at the institute, which would help assess vaccine effectiveness and support India’s indigenous efforts for vaccine development.

Active Covid cases jump from 44 to 51 in Haryana, 11 fresh cases from Gurugram, Faridabad

Active Covid cases jump from 44 to 51 in Haryana, 11 fresh cases from Gurugram, Faridabad

India reports 752 new Covid cases, 4 deaths reported in 24 hours

The number of people recuperated from the disease has increased to 4,44,71,212, and the national recovery rate stands at 98.81%, health ministry said.

As Centre issues advisory amid Covid surge, what is JN.1, the new variant that has reached India

Kerala has reported the first case of JN.1, a descendant of Omicron with a mutation that makes it more infectious. Experts say JN.1 does not appear worrying, but India needs nation-wide serosurvey.

Australia to hold independent inquiry into handling of COVID pandemic

By Renju Jose SYDNEY (Reuters) - Australia's centre-left Labor government on Thursday said it would hold an independent inquiry into the handling of the COVID-19 pandemic to better prepare for future

US First Lady tests positive for Covid days before G20 meet. President Joe Biden tests negative

Jill Biden's symptoms described as mild. President Biden is expected to take regular tests this week before his trip to India for G20 Summit on 8-10 Sept, says a White House statement.

What is new Covid variant Eris, now on WHO’s radar, and what are its symptoms

New Delhi: The emergence of a new SARS-CoV-2 variant, Omicron EG.5.1 — nicknamed 'Eris' — has sparked fresh worries around the globe as the...

Over 10,000 new Covid cases recorded with 19 more deaths

Daily positivity rate was recorded at 4.42% while weekly positivity rate was 4.02%. The active cases now constitute 0.10% of the total infections.

Serum Institute could resume Covishield shot production as Covid cases spike

NEW DELHI (Reuters) - The Serum Institute of India (SII) could resume production of the Covishield COVID-19 vaccine, a company spokesperson said on Wednesday, as infections rise in the country. The

6,050 Covid cases reported Friday, Health Minister to review preparedness with states, UTs

The rise in cases continues unabated as Friday’s numbers show a 13% jump from the day before.

On Camera

India will absorb Trump tariff impact due to its Achilles’ heel

Like China, India remains a big domestic market, which will continue to attract investment, but the US tariffs will make India unattractive for future investments.

New insolvency frameworks to shorter timelines, how 2025 amendment bill proposes to transform IBC

New bill aims to fix key issues with IBC 2016, including delays & patchy implementation, and protect creditors, with window for genuine promoters to retain control of their companies.

‘Peace without power Utopian, lessons from Op Sindoor being implemented’—CDS inaugurates Ran Samvad

India’s 1st tri-service seminar, on the lines of Shangri-La Dialogue, kicks off in Mhow, with top military officers & defence attaches from several countries in attendance.

That Oval Office picture for ages deserves closer Indian reading, with a geopolitical lens

Putin sees this as a victory. Europeans have decided to deal with Trump on his terms for the sake of the larger Western alliance. We look at the lessons for us in India.